Clinical Trials
6 trialsNCT06904378 2026-05-19
ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Washington University School of Medicine
Phase 1/2 Recruiting
NCT06646055 2026-03-09
AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
Akeso
Phase 1/2 Active not recruiting
NCT05630183 2025-11-13
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
Agenus Inc.
Phase 2 Active not recruiting
NCT04581343 2025-05-04
PanCAN-SR1
Pancreatic Cancer Action Network
Phase 1 Completed
NCT03450018 2024-05-24
SLC-0111-17-01
British Columbia Cancer Agency
Phase 1/2 Terminated
NCT03331640 2022-01-11
PANTHEON
AIO-Studien-gGmbH
Phase 2 Terminated